Featured Posts
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Search Posts
News Release
Are Imports the Solution to High Drug Prices?
With the high cost of pharmaceutical drugs playing a central role in the national debate over health care, many policymakers have endorsed the idea…
Newsletter
Custody Disputes, Food Shortages and Taxi Cab Fares
Over 400 children seized from a polygamous sect in Texas are dispersed to group homes and shelters across the state. Zimbabwe, confronted with high food…
Study
Drug Reimportation’s Dangerous Allure
A Misguided Cost-Control Measure Guaranteed to Harm Patient Care…
Newsletter
Sarbanes-Oxley, Cancer Drugs and Discrimination Law
The National Law Journal warns that penalties in the Sarbanes-Oxley accounting rules for public companies can extend to individuals and private entities. Drug maker Cephalon…
Op-Eds
The Empower Eliot Spitzer Bill
Eliot Spitzer announced his resignation yesterday because of his alleged involvement in a prostitution ring. But this is far from his real scandal.
Study
The Five Dumbest Product Bans
This paper focuses on five clearly absurd product bans that seem to serve no social good.